Tom Duthy was previously at Sirtex the cancer drug company. Duthy did a great job at Sirtex despite having a CEO with questionable values. I was invested in Sirtex for a number of years and ended up making a modest gain.
Duthy is a top operator and adds firepower to investor relations at MYX.
- Forums
- ASX - By Stock
- MYX
- Ann: Civil action against Mayne Pharma discontinued in Canada
Ann: Civil action against Mayne Pharma discontinued in Canada, page-23
Featured News
Add MYX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.62 |
Change
0.120(2.67%) |
Mkt cap ! $393.0M |
Open | High | Low | Value | Volume |
$4.57 | $4.64 | $4.50 | $368.1K | 80.46K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25 | $4.62 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.64 | 1200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25 | 4.620 |
2 | 299 | 4.610 |
1 | 114 | 4.600 |
1 | 275 | 4.590 |
2 | 801 | 4.580 |
Price($) | Vol. | No. |
---|---|---|
4.640 | 1200 | 1 |
4.650 | 1246 | 2 |
4.660 | 1601 | 2 |
4.670 | 1801 | 2 |
4.680 | 601 | 1 |
Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
MYX (ASX) Chart |